SLNO
Soleno Therapeutics
SLNO
SLNO
Delisted
SLNO was delisted on the 15th of May, 2026.
223 hedge funds and large institutions have $2.08B invested in Soleno Therapeutics in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 90 increasing their positions, 69 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
31% less capital invested
Capital invested by funds: $3.01B → $2.08B (-$924M)
40% less call options, than puts
Call options by funds: $52M | Put options by funds: $87M
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
223
Holding in Top 10
5
Calls
$52M
Puts
$87M
Top Buyers
| 1 | +$59.3M | |
| 2 | +$43.3M | |
| 3 | +$28.6M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$22M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$22M |
Top Sellers
| 1 | -$89.9M | |
| 2 | -$89.8M | |
| 3 | -$32.5M | |
| 4 |
Millennium Management
New York
|
-$24.7M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$23.5M |
